EPN (Biotechnology) Overview
- Year Founded
-
2015
- Status
-
Out of Business
- Employees
-
29
- Latest Deal Type
-
Out of Business
EPN (Biotechnology) General Information
Description
Manufacturer of molecular diagnostic products designed to support personalised healthcare and early disease detection through genetic and epigenetic analysis. The company offers gene testing technologies, epigenetic biomarker detection platforms and precision diagnostic capabilities, enabling healthcare providers and clinical laboratories to identify disease indicators, improve diagnostic accuracy and support individualised treatment decisions.
Contact Information
Website
www.epican.cnCorporate Office
- Number 500 Huapu Road
- Qingpu District
- Shanghai, 201799
- China
Corporate Office
- Number 500 Huapu Road
- Qingpu District
- Shanghai, 201799
- China
EPN (Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Out of Business | 01-Jan-2023 | Completed | Out of Business | |||
| 4. Secondary Transaction - Private | 20-Dec-2017 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 01-May-2017 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 06-Jul-2016 | $5.34M | $6.92M | Completed | Generating Revenue | |
| 1. Seed Round | 02-Nov-2015 | $1.57M | $1.57M | Completed | Startup |
EPN (Biotechnology) Patents
EPN (Biotechnology) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2019149093-A1 | Gene marker for detecting esophageal cancer, use thereof and detection method therefor | Inactive | 05-Feb-2018 | ||
| WO-2019024578-A1 | Gene marker for detecting benign and malignant liver tumors, kit and detection method | Inactive | 04-Aug-2017 | ||
| WO-2019024579-A1 | Gene marker for detecting lung cancer, kit and lung cancer detection method | Inactive | 04-Aug-2017 | ||
| WO-2018228028-A1 | Gene marker for use in detecting liver cancer and use thereof | Inactive | 16-Jun-2017 | ||
| WO-2018228029-A1 | Gene marker for use in detecting liver cancer and use thereof | Inactive | 16-Jun-2017 | C12Q1/6886 |
EPN (Biotechnology) Signals
EPN (Biotechnology) FAQs
-
When was EPN (Biotechnology) founded?
EPN (Biotechnology) was founded in 2015.
-
Where is EPN (Biotechnology) headquartered?
EPN (Biotechnology) is headquartered in Shanghai, China.
-
What is the size of EPN (Biotechnology)?
EPN (Biotechnology) has 29 total employees.
-
What industry is EPN (Biotechnology) in?
EPN (Biotechnology)’s primary industry is Biotechnology.
-
Is EPN (Biotechnology) a private or public company?
EPN (Biotechnology) is a Private company.
-
What is EPN (Biotechnology)’s current revenue?
The current revenue for EPN (Biotechnology) is .
-
How much funding has EPN (Biotechnology) raised over time?
EPN (Biotechnology) has raised $6.92M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process